Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
32.8M
-
Shares change
-
+6.08M
-
Total reported value, excl. options
-
$805M
-
Value change
-
+$152M
-
Put/Call ratio
-
0.16
-
Number of buys
-
104
-
Number of sells
-
-41
-
Price
-
$24.54
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q3 2015
165 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q3 2015.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.8M shares
of 117M outstanding shares and own 27.97% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (2.98M shares), ORBIMED ADVISORS LLC (2.47M shares), Amici Capital, LLC (1.98M shares), VANGUARD GROUP INC (1.47M shares), STATE STREET CORP (1.32M shares), CITADEL ADVISORS LLC (1.18M shares), Polar Capital LLP (1.08M shares), BlackRock Fund Advisors (959K shares), BlackRock Institutional Trust Company, N.A. (903K shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (888K shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.